207 related articles for article (PubMed ID: 6982719)
1. [Determination of various fractions of complement (Cl, C3c, C3a, C4) in a population of healthy neonates].
Zito GA; Grano S; Gallo AB; Papaleo G; Tripodi V
Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1043-7. PubMed ID: 6982719
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
[TBL] [Abstract][Full Text] [Related]
3. [Normal values of IgA, IgM, IgG, C3c, C4, alpha 1-acid glycoprotein in blood from the umbilical cord of healthy newborn infants using laser-nephelometry. III: C3c, C4, alpha 1-acid glycoprotein].
Tarzia R; Meninno V; Lombardi S; Costanzo A; Canzano G
Boll Soc Ital Biol Sper; 1984 Feb; 60(2):449-54. PubMed ID: 6712808
[TBL] [Abstract][Full Text] [Related]
4. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
5. Complement component analysis in angiodema. Diagnostic value.
Brasher GW; Starr JC; Hall FF; Spiekerman AM
Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
[TBL] [Abstract][Full Text] [Related]
6. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
[TBL] [Abstract][Full Text] [Related]
7. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
8. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
[TBL] [Abstract][Full Text] [Related]
9. [Role of complement in hyaline membrane disease].
Benatre A; Grangeponte MC; Laugier J
Nouv Presse Med; 1976 Jul 3-10; 5(27):1697. PubMed ID: 60739
[No Abstract] [Full Text] [Related]
10. [Development of the serum levels of complement during the first year of life].
Pedraz C; Lorente F; Pedraz MJ; Salazar Villalobos V
An Esp Pediatr; 1980 Jul; 13(7):571-6. PubMed ID: 7416647
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and prognostic value of complement in nephrotic syndromes].
Schena FP; Pertosa G; Vox E; Mastrolitti G
Minerva Nefrol; 1981; 28(3):387-92. PubMed ID: 7036019
[No Abstract] [Full Text] [Related]
12. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
[TBL] [Abstract][Full Text] [Related]
13. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
Santoro F; Bout D; Camus D; Capron A
Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
[No Abstract] [Full Text] [Related]
14. Serum complement profile in human nephritides.
Khanijo V; Gulati PD; Saha K; Rizvi SN
J Assoc Physicians India; 1978 Jan; 26(1):1-11. PubMed ID: 711658
[No Abstract] [Full Text] [Related]
15. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
16. [Effects of the use of FRIGEN (AG-Ffm-HOECST) on the determination of blood levels of some proteins (IgA, IgM, IgG, C3c, C4) in cord blood of healthy newborn infants at term by laser nephelometry].
Costanzo A; Meninno V; Addeo L; Canzano G; Lombardi S
Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1811-7. PubMed ID: 6525301
[TBL] [Abstract][Full Text] [Related]
17. Influence of gestational age on cord blood immunoglobulin and complement levels.
Kumar A; Jauhari P; Singh U; Singla PN
Indian Pediatr; 1996 Jan; 33(1):44-6. PubMed ID: 8772952
[No Abstract] [Full Text] [Related]
18. Secretor state and complement levels (C3 and C4) in insulin dependent diabetes mellitus.
Blackwell CC; Weir DM; Patrick AW; Collier A; Clarke BF
Diabetes Res; 1988 Nov; 9(3):117-9. PubMed ID: 3243044
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
Danese C; Marcianò F; Ciarla MV; Colotto M; Angrisani L; Ferranti E; Borgia MC
Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
[TBL] [Abstract][Full Text] [Related]
20. [Complement study in 40 children with acute and chronic viral hepatitis of HB origin].
Dupuy C; Lafforêt D; Dupuy JM
Arch Fr Pediatr; 1977; 34(7 Suppl):CLXXXIV-CXCVI. PubMed ID: 931524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
